News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,077 Results
Type
Article (43698)
Company Profile (356)
Press Release (668023)
Section
Business (212027)
Career Advice (2079)
Deals (36426)
Drug Delivery (92)
Drug Development (82297)
Employer Resources (172)
FDA (16713)
Job Trends (15306)
News (356255)
Policy (33451)
Tag
Academia (2701)
Alliances (52267)
Alzheimer's disease (1226)
Approvals (16625)
Artificial intelligence (114)
Bankruptcy (357)
Best Places to Work (11716)
Biotechnology (252)
Breast cancer (87)
Cancer (745)
Career advice (1736)
Cell therapy (185)
Clinical research (64613)
Collaboration (259)
Compensation (147)
COVID-19 (2621)
Cystic fibrosis (81)
Data (604)
Diabetes (108)
Diagnostics (6318)
Drug pricing (78)
Earnings (85493)
Employer resources (150)
Events (113218)
Executive appointments (230)
FDA (17074)
Funding (246)
Gene therapy (132)
GLP-1 (554)
Government (4446)
Healthcare (19414)
Infectious disease (2678)
Inflammatory bowel disease (101)
Interviews (321)
IPO (16602)
Job creations (3825)
Job search strategy (1489)
Layoffs (421)
Legal (8072)
Lung cancer (143)
Manufacturing (130)
Medical device (13844)
Medtech (13849)
Mergers & acquisitions (19791)
Metabolic disorders (319)
Neuroscience (1439)
NextGen Class of 2024 (6844)
Non-profit (4633)
Northern California (1040)
Obesity (191)
Opinion (189)
Patents (90)
People (58430)
Pharmaceutical (72)
Phase I (20172)
Phase II (28407)
Phase III (21191)
Pipeline (165)
Postmarket research (2579)
Preclinical (8634)
Radiopharmaceuticals (249)
Rare diseases (165)
Real estate (6245)
Regulatory (22042)
Research institute (2471)
Resumes & cover letters (359)
Southern California (971)
Startups (3847)
United States (10645)
Vaccines (543)
Weight loss (149)
Date
Today (160)
Last 7 days (630)
Last 30 days (2734)
Last 365 days (37641)
2024 (29528)
2023 (41303)
2022 (52541)
2021 (57172)
2020 (55794)
2019 (48569)
2018 (36569)
2017 (33659)
2016 (33260)
2015 (39464)
2014 (33059)
2013 (28097)
2012 (30338)
2011 (30934)
2010 (28886)
Location
Africa (758)
Arizona (191)
Asia (39723)
Australia (6604)
California (2428)
Canada (1085)
China (185)
Colorado (102)
Connecticut (107)
Europe (86858)
Florida (340)
Georgia (89)
Illinois (308)
Indiana (170)
Kansas (98)
Maryland (477)
Massachusetts (1973)
Michigan (150)
Minnesota (246)
New Jersey (724)
New York (739)
North Carolina (675)
Northern California (1040)
Ohio (119)
Pennsylvania (687)
South America (1155)
Southern California (971)
Texas (334)
Washington State (298)
712,077 Results for "accelerated technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
5 Accelerated Approvals Gone Wrong
Since its inception in 1992, the FDA’s accelerated approval pathway has helped shepherd nearly 300 new drugs to the market. However, recent years have seen a number of high-profile market withdrawals and failed confirmatory trials.
October 14, 2024
·
7 min read
·
Heather McKenzie
Pharm Country
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc.
May 22, 2024
·
7 min read
Business
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
bioAffinity Technologies, Inc. today announced David Elzi, Ph.D., has been named Vice President of Product Development to accelerate the development of new diagnostics based on the proprietary technology platform behind CyPath® Lung, the Company’s commercial test for the detection of early-stage lung cancer.
April 24, 2024
·
6 min read
Lone Star Bio
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
bioAffinity Technologies, Inc. reported accelerating growth of 375% in CyPath® Lung tests ordered and processed over the past three months as compared to the previous three months.
March 5, 2024
·
5 min read
Biotech Bay
AbTherx Opens Antibody Discovery Technologies Research Center
AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the opening of its new antibody discovery technologies research center.
June 18, 2024
·
3 min read
Press Releases
INCOG BioPharma Accelerates Expansion Plans
October 10, 2024
·
4 min read
Lone Star Bio
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
bioAffinity Technologies, Inc., a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, reported 139% growth in the number of pulmonology practices and physicians offering CyPath® Lung to patients since Jan. 1, 2024.
June 12, 2024
·
6 min read
Business
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
bioAffinity Technologies, Inc., a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, reported financial results for the three months ended March 31, 2024.
May 15, 2024
·
10 min read
FDA
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
September 30, 2024
·
6 min read
Biotech Bay
Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing
Mekonos, Inc. announced it has entered into a partnership agreement with Accelerated Biosciences Corp. to codevelop a powerful, new manufacturing cell line based on Accelerated Bio’s human Trophoblast Stem Cells and Gene Engineered Multi-Sites technology.
May 2, 2024
·
4 min read
1 of 71,208
Next
